We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Professor Ernest Choy at Spire include:
Treatment of rheumatoid arthritis
I am Head of Rheumatology and Translational Research at the Institute of Infection and Immunity and Director of the Cardiff Regional Experimental Arthritis Treatment and Evaluation (CREATE) Centre at Cardiff University School of Medicine, Cardiff, Wales, UK. I am also Honorary Consultant Rheumatologist at University Hospital of Wales and Clinical Lead of the Welsh Arthritis Research Network (WARN). Previously, I was Reader and Director of the King’s Musculoskeletal Clinical Trials Unit in the Academic Department of Rheumatology, King’s College London.
My major research interest is the treatment of rheumatic diseases focusing on the efficiency of new treatment strategies.
I was Director of Research and Development at King's College Hospital between 2003-2008. I am a member of the European League Against Rheumatism Committee Standing Committee for International Clinical Studies Including Therapeutic Trials. I chair the EULAR Taskforce on developing recommendations for management and classification criteria for fibromyalgia. I have served as clinical expert to the National Institute for Clinical Excellence in the UK and many pharmaceutical companies.
I am a frequent lecturer on the treatment of rheumatic diseases.
Psoriatic arthritis and fibromyalgia
Professor of Rheumatology, Cardiff & Vale University Health Board.
Professor and Head of Rheumatology, Cardiff University.
Back to top
Holds less than 0.1% of the shares in Spire Healthcare Group PLC.Back to top
|Telephone||029 2073 6011|
|Private secretary||Rebecca David|
|Private secretary firstname.lastname@example.org|
24 September 2018
At Spire Hospitals we work with a number of leading orthopaedic consultants, specialising in the treatment of spinal con…